Baidu
map

整形科指南

订阅

MedSci主页 / 所有栏目 / 整形科指南

亚洲医疗美容行业趋势，态度和概念专家共识

2020-08-02 Aesthetic Plast Surg . 2020 Aug;44(4):1186-1194.

美容院整形美容医学美容

背景：亚洲人越来越多地寻求非手术的面部美容治疗，尤其是在年轻的时候。亚洲人越来越多地寻求非手术的面部美容治疗，尤其是在年轻时。已发表的建议和临床证据大多参考西方人群，但亚洲人在对美的态度、面部结构解剖

中文标题：

亚洲医疗美容行业趋势，态度和概念专家共识

英文标题：

Consensus on Changing Trends, Attitudes, and Concepts of Asian Beauty

发布机构：

发布日期：

2020-08-02

简要介绍：

背景：亚洲人越来越多地寻求非手术的面部美容治疗，尤其是在年轻的时候。亚洲人越来越多地寻求非手术的面部美容治疗，尤其是在年轻时。已发表的建议和临床证据大多参考西方人群，但亚洲人在对美的态度、面部结构解剖学、衰老的迹象和速度方面与他们不同。对亚洲人脸部的主要美容问题和要求有全面的了解，才能制定适当的肉毒杆菌毒素和透明质酸（HA）填充剂的面部美容治疗策略。

方法。亚洲面部美学专家共识小组召开会议，就东南亚和东亚人的面部美学概念、主要的美学关注、面部解剖学和衰老问题达成共识，作为发展共识意见的前奏，以便在这些人群中使用肉毒杆菌毒素和HA填充物进行面部美容。

结果。所有种族的美丽和美学吸引力的人在外观上都有相似之处，同时又保留着独特的民族特征。与年龄匹配的白种人相比，第三至六十年间的亚洲人年龄增长良好。年轻的亚洲人越来越多地要求进行注射治疗，以改善面部形状和立体感，这往往反映出他们希望纠正潜在的面部结构缺陷或弱点，这有损于面部美容的理想。

结论：亚洲人的面部美容治疗 亚洲人的面部美容治疗并不是以西化为目的，而是以优化亚洲人固有的民族特征为目的，或者纠正被认为是缺陷的特定潜在结构特征。因此，在保留亚洲人种审美特征的同时，整体面部吸引力得到提升。由于亚洲患者的年龄与西方患者不同，因此采用不同的管理和治疗计划策略。证据等级V 本刊要求作者为每篇文章指定一个证据等级。

相关资料下载：
[AttachmentFileName(sort=1, fileName=10.1136@archdischild-2020-320164.pdf)] GetToolGuiderByIdResponse(projectId=1, id=487dc1c001958a27, title=亚洲医疗美容行业趋势，态度和概念专家共识, enTitle=Consensus on Changing Trends, Attitudes, and Concepts of Asian Beauty, guiderFrom=Aesthetic Plast Surg . 2020 Aug;44(4):1186-1194., authorId=0, author=, summary=背景：亚洲人越来越多地寻求非手术的面部美容治疗，尤其是在年轻的时候。亚洲人越来越多地寻求非手术的面部美容治疗，尤其是在年轻时。已发表的建议和临床证据大多参考西方人群，但亚洲人在对美的态度、面部结构解剖, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Aug 02 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>背景：亚洲人越来越多地寻求非手术的面部美容治疗，尤其是在年轻的时候。亚洲人越来越多地寻求非手术的面部美容治疗，尤其是在年轻时。已发表的建议和临床证据大多参考西方人群，但亚洲人在对美的态度、面部结构解剖学、衰老的迹象和速度方面与他们不同。对亚洲人脸部的主要美容问题和要求有全面的了解，才能制定适当的肉毒杆菌毒素和透明质酸（HA）填充剂的面部美容治疗策略。</p> <p>方法。亚洲面部美学专家共识小组召开会议，就东南亚和东亚人的面部美学概念、主要的美学关注、面部解剖学和衰老问题达成共识，作为发展共识意见的前奏，以便在这些人群中使用肉毒杆菌毒素和HA填充物进行面部美容。</p> <p>结果。所有种族的美丽和美学吸引力的人在外观上都有相似之处，同时又保留着独特的民族特征。与年龄匹配的白种人相比，第三至六十年间的亚洲人年龄增长良好。年轻的亚洲人越来越多地要求进行注射治疗，以改善面部形状和立体感，这往往反映出他们希望纠正潜在的面部结构缺陷或弱点，这有损于面部美容的理想。</p> <p>结论：亚洲人的面部美容治疗 亚洲人的面部美容治疗并不是以西化为目的，而是以优化亚洲人固有的民族特征为目的，或者纠正被认为是缺陷的特定潜在结构特征。因此，在保留亚洲人种审美特征的同时，整体面部吸引力得到提升。由于亚洲患者的年龄与西方患者不同，因此采用不同的管理和治疗计划策略。证据等级V 本刊要求作者为每篇文章指定一个证据等级。</p>, tagList=[TagDto(tagId=167, tagName=美容院), TagDto(tagId=6144, tagName=整形美容), TagDto(tagId=33836, tagName=医学美容)], categoryList=[CategoryDto(categoryId=28, categoryName=整形科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7734, appHits=80, showAppHits=0, pcHits=542, showPcHits=7654, likes=3, shares=3, comments=4, approvalStatus=1, publishedTime=Sat Aug 29 21:53:52 CST 2020, publishedTimeString=2020-08-02, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sat Aug 29 21:53:46 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Thu Jan 04 18:59:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=10.1136@archdischild-2020-320164.pdf)])
10.1136@archdischild-2020-320164.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=996465, encodeId=5d9e99646556, content=下载不了啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfac5541944, createdName=iris6898, createdTime=Mon Jul 05 17:00:20 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893192, encodeId=d5d589319251, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200930/e0fbd563d9054278997cb567f3351d90/db37f938d1ea4a96a7e324c062c9461b.jpg, createdBy=3d615392683, createdName=我是梁, createdTime=Mon Oct 19 23:46:30 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881978, encodeId=e96f8819e8ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e77f5156855, createdName=146aa4aam90(暂无昵称), createdTime=Wed Sep 02 07:21:56 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881318, encodeId=4d9a881318a8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 31 12:21:47 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2021-07-05 iris6898

    下载不了啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=996465, encodeId=5d9e99646556, content=下载不了啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfac5541944, createdName=iris6898, createdTime=Mon Jul 05 17:00:20 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893192, encodeId=d5d589319251, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200930/e0fbd563d9054278997cb567f3351d90/db37f938d1ea4a96a7e324c062c9461b.jpg, createdBy=3d615392683, createdName=我是梁, createdTime=Mon Oct 19 23:46:30 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881978, encodeId=e96f8819e8ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e77f5156855, createdName=146aa4aam90(暂无昵称), createdTime=Wed Sep 02 07:21:56 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881318, encodeId=4d9a881318a8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 31 12:21:47 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-10-19 我是梁

    很好，学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=996465, encodeId=5d9e99646556, content=下载不了啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfac5541944, createdName=iris6898, createdTime=Mon Jul 05 17:00:20 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893192, encodeId=d5d589319251, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200930/e0fbd563d9054278997cb567f3351d90/db37f938d1ea4a96a7e324c062c9461b.jpg, createdBy=3d615392683, createdName=我是梁, createdTime=Mon Oct 19 23:46:30 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881978, encodeId=e96f8819e8ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e77f5156855, createdName=146aa4aam90(暂无昵称), createdTime=Wed Sep 02 07:21:56 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881318, encodeId=4d9a881318a8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 31 12:21:47 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-09-02 146aa4aam90(暂无昵称)

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=996465, encodeId=5d9e99646556, content=下载不了啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfac5541944, createdName=iris6898, createdTime=Mon Jul 05 17:00:20 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893192, encodeId=d5d589319251, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200930/e0fbd563d9054278997cb567f3351d90/db37f938d1ea4a96a7e324c062c9461b.jpg, createdBy=3d615392683, createdName=我是梁, createdTime=Mon Oct 19 23:46:30 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881978, encodeId=e96f8819e8ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e77f5156855, createdName=146aa4aam90(暂无昵称), createdTime=Wed Sep 02 07:21:56 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881318, encodeId=4d9a881318a8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 31 12:21:47 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 1209e435m98(暂无昵称)

    学习了，谢谢分享

    0

Baidu
map
Baidu
map
Baidu
map